Inpatient, outpatient and domiciliary management;Scompenso cardiaco refrattario. Modelli di gestione ospedaliera, ambulatoriale e domiciliare

Italian Heart Journal Supplement

Volumn 3, Issue 8, 2002, Pages 837-850

  Oliva, Fabrizio ^a   Alunni, Gianfranco ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Chronic heart failure; Management in cardiology; Medical therapy; Outpatient management

Indexed keywords

COMORBIDITY; HEALTH CARE COST; HEART FAILURE; HEART OUTPUT; HOME CARE; HOSPITAL CARE; HOSPITALIZATION; HUMAN; OUTPATIENT CARE; PATIENT EDUCATION; REVIEW; SOCIAL SUPPORT; AMBULATORY CARE; CONGESTIVE HEART FAILURE; PATIENT COMPLIANCE; PROGNOSIS;

AMBULATORY CARE; HEART FAILURE, CONGESTIVE; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; PATIENT COMPLIANCE; PROGNOSIS;

EID: 0242364192     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997; 18: 205-25.
2. Szucs TD. The growing healthcare burden of CHF. J Renin Angiotensin Aldosterone Syst 2000; 1 (Suppl 1): 2-6.
3. Berry C, McMurray J. A review of quality-of-life evaluations in patients with congestive heart failure. Pharmacoeconomics 1999; 16: 247-71.
4. McMurray J, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596-602.
5. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-15.
6. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-33.
7. Remme WJ, Swedberg K, for the Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-60.
8. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994; 272: 1528-34.
9. Blitz A, Laks H. The role of coronary revascularization in the management of heart failure: identification of candidates and review of results. Curr Opin Cardiol 1996; 11: 276-90.
10. Bolling SF, Pagani FD, Deeb MG, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115: 381-8.
11. Stevenson LW, Brunken RC, Belil D, et al. Afterload reduction with vasodilators and diuretics decreases mitral valve regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol 1990; 15: 174-80.
12. Dracup K, Baker DV, Dunbar SB, et al. Management of heart failure. II. Counseling, education and lifestyle modifications. JAMA 1994; 272: 1442-6.
13. Stevenson LW, Massie BM, Francis GS. Optimizing therapy for complex or refractory heart failure: a management algorithm. Am Heart J 1998; 135 (Part 2): S293-S309.
14. Haeusslein EA, Greenberg BH, Massie BM. Does the magnitude of mitral regurgitation determine hemodynamic response to vasodilation in chronic congestive heart failure? Chest 1991; 100: 1312-5.
15. Pepi M, Marenzi GC, Agostoni PG, et al. Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates. Br Heart J 1993; 70: 136-40.
16. Feldman AM, Bristow MR, Parmley WW, et al. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med 1993; 329: 149-55.
17. Feldman A, Young J, Bourge R, et al. Mechanism of increased mortality from vesnarinone in the severe heart failure trial (VEST). (abstr) J Am Coll Cardiol 1997; 29: 64A.
18. Packer M, Rouleau J, Swedberg K, et al. Effect of flosequinan on survival in chronic heart failure. Preliminary results of the PROFILE study. (abstr) Circulation 1993; 88: 1301.
19. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325: 1468-75.
20. Berkowitz C, McKeever L, Croke RP, Jacobs WR, Loeb HS, Gunnar RM. Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure. Circulation 1977; 56: 918-24.
21. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 1996; 335: 1107-14.
22. Littler WA, Sheridan DJ. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group. Br Heart J 1995; 73: 428-33.
23. Frigerio M, Gronda E, Mangiavacchi M. Guida al trattamento intensivo dello scompenso cardiaco refrattario. G Ital Cardiol 1994; 24: 1275-84.
24. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-17.
25. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997; 336: 525-33.
26. Watson RDS, Gibbs CR, Lip GYH. ABC of heart failure: clinical features and complications. BMJ 2000; 320: 236-9.
27. Davie AP, MacMurray JJ. ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians? Postgrad Med J 1999; 75: 219-22.
28. McColl A, Roderick P, Gabbay J, Smith H, Moore M. Performance indicators for primary care groups: an evidence based approach. BMJ 1998; 317: 1354-60.
29. Dies F, Krell MJ, Whitlow P, et al. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. (abstr) Circulation 1986; 74 (Suppl II): 11-39.
30. Oliva F, Latini R, Politi A, et al. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J 1999; 138 (Part 1): 247-53.
31. Young JB, Moen EK. Outpatient parenteral inotropic therapy for advanced heart failure. J Heart Lung Transplant 2000; 19 (Suppl): S49-S57.
32. Oliva F, Gronda E, Frigero M, et al. Outpatient intermittent dobutamine therapy in congestive heart failure. Z Kardiol 1999; 88 (Suppl 3): S28-S32.
33. Capomolla S, Febo O, Opasich C, et al. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome. Eur J Heart Fail 2001; 3: 601-10.
34. Stewart S, Pearson S. Uncovering a multitude of sins: medication management in the home post acute hospitalisation among the chronically ill. Aust NZJ Med 1999; 29: 220-7.
35. Leider HL. Heart failure and disease management. Am J Manag Care 1998; 4 (Suppl): S343-S348.
36. Bjork A, Linnè H, Liedholm B, et al. Effects of systematic education on heart failure patients knowledge after 6 months. A randomized controlled trial. Eur J Heart Fail 1999; 1: 219-27.
37. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-5.
38. Fried TR, van Doorn C, O'Leary JR, Tinetti ME, Drickamer MA. Older persons' perceptions of home and hospital as sites of treatment for acute illness. Am J Med 1999; 107: 317-23.
39. McMurray JJV, Stewart S. Nurse led, multidisciplinary intervention in chronic heart failure. Heart 1998; 80: 430-1.
40. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet 1999; 354: 1077-83.
41. Cline CM, Israelsson BY, Willenheimer RB, Broms K, Erhardt LR. Cost effective management programme for heart failure reduces hospitalisation. Heart 1998; 80: 442-6.
42. Kornowsky R, Zeeli D, Averbuch M, et al. Intensive homecare surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995; 129: 762-6.
43. West JA, Miller NH, Parker KM, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 1997; 79: 58-63.
44. Wilson JR, Smith JS, Dahle KL, Ingersoll GL. Impact of home health care on health care costs and hospitalization frequency in patients with heart failure. Am J Cardiol 1999; 83: 615-7.
45. Abraham WT, Bristow MR. Specialized centers for heart failure management. Circulation 1997; 96: 2755-7.
46. Rajfer SI. Perspective of the pharmaceutical industry on the development of new drugs for heart failure. J Am Coll Cardiol 1993; 22 (Suppl A): 198A-200A.
47. Havranek EP, Graham GW, Pan Z, et al. Process and outcome of outpatient management of heart failure: a comparison of cardiologist and primary care providers. Am J Manag Care 1996; 2: 783-9.
48. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-80.